Leishmaniasis, resulting from
infection with the protozoan parasite Leishmania, consists of a wide spectrum of clinical manifestations, from healing cutaneous lesions to fatal visceral
infections. A particularly severe form of
cutaneous leishmaniasis, termed mucosal
leishmaniasis, exhibits decreased
IL-10 levels and an exaggerated inflammatory response that perpetuates the disease. Using a mouse model of
leishmaniasis, we investigated what
cytokines contribute to increased pathology when IL-10-mediated regulation is absent. Leishmania major infected C57BL/6 mice lacking
IL-10 regulation developed larger lesions than controls, but fewer parasites. Both IFN-γ and
IL-17 levels were substantially elevated in mice lacking the capacity to respond to
IL-10. IFN-γ promoted an increased infiltration of monocytes, while
IL-17 contributed to an increase in neutrophils. Surprisingly, however, we found that IFN-γ did not contribute to increased pathology, but instead regulated the
IL-17 response. Thus, blocking IFN-γ led to a significant increase in
IL-17, neutrophils and disease. Similarly, the production of
IL-17 by cells from
leishmaniasis patients was also regulated by
IL-10 and IFN-γ. Additional studies found that the
IL-1 receptor was required for both the
IL-17 response and increased pathology. Therefore, we propose that regulating
IL-17, possibly by downregulating IL-1β, may be a useful approach for controlling immunopathology in
leishmaniasis.